The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer
Crossref DOI link: https://doi.org/10.1245/s10434-016-5684-3
Published Online: 2016-11-21
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dreyer, Stephan B.
Powell, Arfon G. M. T.
McSorley, Stephen T.
Waterston, Ashita
Going, James J.
Edwards, Joanne
McMillan, Donald C.
Horgan, Paul G.
License valid from 2016-11-21